Find your next paid study

Montefiore Medical CenterNCT05721027

~$25 – $1,000

Actual pay is set by the research site.

PovertyEducation Advancement

Negative Income Tax Trial

In partnership with a local community college in in Omaha, Nebraska, the Center for Guaranteed Income Research (CGIR) at the University of Pennsylvania will co…

University of PennsylvaniaNCT07463131

Actual pay is set by the research site.

Phase 2

A Phase 2 Study of Intratumoral Administration of L19IL2/L19TNF in Locally Advanced Basal Cell Carcinoma Patients Progressing or Intolerant to Systemic Treatment.

Open-label, single-arm, multicentre study in patients with locally advanced BCC amenable to intratumoral injection, who have progressed on or are intolerant to…

Locally Advanced Basal Cell Carcinoma

Philogen S.p.A.NCT07227870

~$75 – $3,000

Actual pay is set by the research site.

Substance AbuseSubstance AddictionSubstance Use Disorder (SUD)+2 more

A Gender-Affirming Stigma Intervention to Improve Substance Misuse and HIV Risk Among Transgender Women

This study is testing a new mutual-help group called "the TLC program" for transgender adults who use substances or are recently in recovery. The TLC Program i…

Illinois Institute of TechnologyNCT06880705

Actual pay is set by the research site.

Phase 2

A Phase 2a, Multicenter, Randomized, Open-Label Study to Assess the Efficacy, Safety, and Tolerability of RBS2418 in Combination With Tremelimumab Plus Durvalumab for Participants With Advanced Unresectable Hepatocellular Carcinoma

RBS2418 is a targeted immune modulator that inhibits ectonucleotide pyrophosphatase/phosphodiesterase 1 (ENPP1). It is designed to promote anti-tumor immunity …

Advanced Unresectable Hepatocellular Carcinoma

Riboscience, LLC.NCT07175441

~$75 – $2,800

Actual pay is set by the research site.

Pelvic RadiotherapyVaginal StenosisPelvic Cancer+3 more

Improving Engagement With Vaginal Dilator Therapy After Pelvic Radiation: A Pilot Randomized Controlled Trial

This study is testing a new program to help women who have had pelvic radiation therapy to use vaginal dilators more regularly. Vaginal dilators are important …

Duke UniversityNCT07216456

Actual pay is set by the research site.

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

To learn how radiation treatment may affect your responses to vaccines against pneumonia.

Pneumococcal VaccineEsophageal CancerLymphopenia+1 more

Pay not disclosed — ask the coordinator

M.D. Anderson Cancer CenterNCT06181656

Program EngagementTreatment Adherence and ComplianceMindfulness+5 more

Choice and Autonomy in Learning Mindfulness for Pediatric Residents

This study is a pilot clinical trial designed to evaluate a flexible, online mindfulness program for pediatric residents. Medical training can be stressful, an…

Northwestern UniversityNCT07542769

Actual pay is set by the research site.

Genetic Studies in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)

Interstitial cystitis (IC), also called Bladder Pain syndrome (BPS) is a common condition with no known cause or cure. Twin studies and family accounts have su…

Interstitial CystitisBladder Pain Syndrome

Boston Children's HospitalNCT00389142

Actual pay is set by the research site.

StrokeAphasiaReading Disorder

Improving Reading Competence in Aphasia With Combined Aerobic Exercise and Phono-Motor Treatment

The goal of the proposed project is to test the effectiveness of a novel hybrid approach to treatment of reading disorders after stroke, in which exercise trai…

Kessler FoundationNCT06213272

Actual pay is set by the research site.

Phase 3

Phase III Double Blinded Trial of Immune-Based Therapy With a Live Biotherapeutic MO-03 or Placebo for Frontline Therapy of Advanced Clear Cell Renal Cell Carcinoma [BioFront Trial]

This phase III trial compares the effect of adding live biotherapy, MO-03, to standard of care (SOC) immunotherapy, including ipilimumab, nivolumab, axitinib, …

Advanced Clear Cell Renal Cell CarcinomaMetastatic Clear Cell Renal Cell CarcinomaStage III Renal Cell Cancer AJCC v8+1 more

SWOG Cancer Research NetworkNCT07383441

~$50 – $2,250

Actual pay is set by the research site.

Phase 3

A Phase 3 Multicenter, Randomized, Open-label Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab Versus Standard of Care in the First-line Treatment of Patients With Locoregional Recurrence of Squamous Cell Carcinoma of the Head and Neck (HNSCC) With No Distant Metastases

The goal of this clinical trial is to learn if ASP-1929 photoimmunotherapy (PIT) in combination with pembrolizumab works to treat recurrent squamous cell cance…

Recurrent Head and Neck Squamous Cell Carcinoma